• OPEN AN ACCOUNT
Indian Indices
Nifty
26,033.75 47.75
(0.18%)
Sensex
85,712.37 447.05
( 0.52%)
Bank Nifty
59,288.70 -59.55
( -0.10%)
Nifty IT
38,360.25 535.00
( 1.41%)
Global Indices
Nasdaq
47,874.44 -29.46
(-0.06%)
Dow Jones
6,878.17 7.45
(0.11%)
Hang Seng
50,440.45 -587.97
(-1.15%)
Nikkei 225
9,722.32 30.25
(0.31%)
Forex
USD-INR
90.13 0.27
(0.30%)
EUR-INR
105.04 0.70
(0.67%)
GBP-INR
119.76 1.10
(0.93%)
JPY-INR
0.58 0.00
(0.57%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
377.5672424
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
19.74
106581.13
EPS(TTM)
Face Value()
Div & Yield %
64.68
1
0.63
 

As on: Dec 05, 2025 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
1,275.05 -1.95 164697 19.74
Stock Price Details
Open Price() 1,277.00
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 1,282.70
Today's Low () 1,271.95
52-Week High () 1404.6
152-Week Low () 1025.9
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.63
Eps 64.68
Book Value 377.5672424
Market Cap (.Cr) 106,581.13
Face Value 1
Market Lot 1
AGM Date Jul
Book Closure Date Jul
ISIN No. INE089A01031


News
Dr Reddys Laboratories Ltd up for five straight sessions
Dr Reddys Lab gains after securing EC nod for AVT03
Dr. Reddy's receives EC marketing authorization for AVT03 (denosumab)
Dr Reddys Laboratories Ltd up for fifth session
Dr Reddys Laboratories allots 7,430 equity shares under ESOS
Dr. Reddy’s, Shaily Engineering tumble after delay in Semaglutide approval
Dr Reddy's Laboratories consolidated net profit rises 7.28% in the September 2025 quarter
Dr Reddys Lab Q2 PAT jumps 14% YoY to Rs 1,437 cr
Dr Reddys Laboratories Ltd - Dr. Reddys Laboratories Limited - Outcome of Board Meeting
Dr Reddys Laboratories Ltd soars 1.97%, rises for third straight session
More
Corporate Details
Incoporation Year   : 1984
Chairman : K Satish Reddy
Bussiness Group : Dr. Reddy's
Registered Office
Dr Reddys Laboratories Ltd
8-2-337 Road No 3,
Banjara Hills,
Hyderabad,
Telangana-500034
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-40-49002900
Fax:91-40-49002999
Fax:91-22-66317458
E-Mail : shares@drreddys.com; mail@drreddys.com
URL : http://www.drreddys.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 100
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE Shariah 50
  • bse carbonex
  • NIFTY
  • CNX 500
  • CNX 100
  • CNX Pharma
  • CNX 200
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi